KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Accured Expenses (2016 - 2019)

Historic Change in Accured Expenses for Thermo Fisher Scientific (TMO) over the last 11 years, with Q4 2019 value amounting to $38.0 million.

  • Thermo Fisher Scientific's Change in Accured Expenses fell 7579.62% to $38.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $210.0 million, marking a year-over-year increase of 60000.0%. This contributed to the annual value of $210.0 million for FY2019, which is 60000.0% up from last year.
  • Per Thermo Fisher Scientific's latest filing, its Change in Accured Expenses stood at $38.0 million for Q4 2019, which was down 7579.62% from -$147.0 million recorded in Q3 2019.
  • Thermo Fisher Scientific's Change in Accured Expenses' 5-year high stood at $992.0 million during Q4 2017, with a 5-year trough of -$471.0 million in Q1 2018.
  • For the 5-year period, Thermo Fisher Scientific's Change in Accured Expenses averaged around $80.0 million, with its median value being $115.2 million (2015).
  • Over the last 5 years, Thermo Fisher Scientific's Change in Accured Expenses had its largest YoY gain of 1201944.44% in 2015, and its largest YoY loss of 24797.9% in 2015.
  • Thermo Fisher Scientific's Change in Accured Expenses (Quarter) stood at $436.3 million in 2015, then decreased by 16.89% to $362.6 million in 2016, then surged by 173.58% to $992.0 million in 2017, then tumbled by 84.17% to $157.0 million in 2018, then plummeted by 75.8% to $38.0 million in 2019.
  • Its Change in Accured Expenses was $38.0 million in Q4 2019, compared to -$147.0 million in Q3 2019 and $549.0 million in Q2 2019.